Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-12-03T00:48:00.450Z Has data issue: false hasContentIssue false

Chronic Inflammatory Demyelinating Polyneuropathy and Metastatic Melanoma

Published online by Cambridge University Press:  23 September 2014

Anthony M.T. Chau
Affiliation:
University of Sydney, Sydney, Australia, Email: [email protected]
Amy Yu
Affiliation:
McGill University, Montréal, Quebec, Canada
Mark R. Keezer
Affiliation:
McGill University, Montréal, Quebec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1.Anthoney, DA, Bone, I, Evans, TR.Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma. Ann Oncol. 2000;11(9):1197–200.Google Scholar
2.Bird, SJ, Brown, MJ, Shy, ME, Scherer, SS.Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma. Neurology. 1996;46(3):8224.Google Scholar
3.Palma, J-A, Martin-Algarra, S.Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin. J Neurooncol. 2009;94(2):279–81.Google Scholar
4.Rousseau, A, Salachas, F, Baccard, M, Delattre, JY, Sanson, M.Chronic inflammatory polyneuropathy revealing malignant melanoma. J Neurooncol. 2005;71(3):3356.CrossRefGoogle ScholarPubMed
5.Weiss, MD, Luciano, CA, Semino-Mora, C, Dalakas, MC, Quarles, RH.Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology. 1998;51(6):173841.CrossRefGoogle ScholarPubMed